Skip to content

Research on Accurate Prediction of Long-term Medication Use for Schizophrenia Based on Cognitive Function

Research on Accurate Prediction of Long-term Medication Use for Schizophrenia Based on Cognitive Function

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04513275
Enrollment
500
Registered
2020-08-14
Start date
2020-10-01
Completion date
2022-09-30
Last updated
2020-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-medicine Intervention

Brief summary

Chinese version of the cognitive function test of schizophrenia (MCCB) . To explore a predictive model for long-term medication use in patients based on cognitive function

Interventions

DRUGnon-medicine intervention

rating by MCCB only one time

Sponsors

Shanghai Mental Health Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Schizophrenia patients with first episode and disease duration of 5, 10, 20, and 30 years \_Meet the diagnostic criteria for schizophrenia in ICD-10

Exclusion criteria

* Other people with mental illness

Design outcomes

Primary

MeasureTime frame
Score of MATRICS Consensus Cognitive Battery1 day (only one time)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026